←
Nature Medicine12,924 posts
Nature Medicine avatar✓

Nature Medicine ✓

@NatureMedicine

Nature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.

◷ Joined March 2009▧ 2,621 Photos and videos
Nature Medicine avatar
Nature Medicine@NatureMedicine·1h

News & Views: A long noncoding RNA could be a promising noninvasive biomarker for detecting premalignant and early stage #ovariancancer, for which sensitive screening methods are currently lacking. dlvr.​it/TWNHh8

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Nov 16

As presented at #CTAD2026: OpenScientist, an open-source AI co-scientist, reproduced expert findings and generated testable hypotheses across expert-evaluated biomedical studies, including air-gapped runs on open-weight models. dlvr.​it/TWM9kb

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Nov 5

New Perspective: A group of policymakers and researchers discuss the impacts of #climatechange on #malaria in the Asia Pacific; they identify gaps in national adaptation strategies and propose five priority actions for the region. dlvr.​it/TWCW4K

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Nov 2

A 5-year analysis of the phase 2 PHERGain trial supports the clinical utility of a PET-guided adaptive strategy for treatment de-escalation in HER2+ early breast cancer, and provides ctDNA insights to inform future treatment de-escalation approaches. dlvr.​it/TW8d7w

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 30

In ALS, persistent T cell responses relate to disease outcome differently in blood than in CSF, with both intrathecal antigen presentation and cytomegalovirus-specific immunity linked to worse clinical outcomes. dlvr.​it/TW72Zk

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 30

A multimodal vision language foundation model, EVLF-FM, integrates extensive clinical data and training techniques, achieving superior diagnostic accuracy and explainability across diverse imaging modalities. dlvr.​it/TW6x3W

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 30

A high-resolution snRNA-seq atlas including data from 189 colorectal cancers from patients aged 20-90+ years uncovers age-associated features of colorectal cancer. dlvr.​it/TW6sdj

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 29

Metabolic heterogeneity of obesity: Sam Klein & colleagues examine the differences between metabolically healthy and metabolically unhealthy obesity, as well as variations in response to weight loss and clinical implications. dlvr.​it/TW65gK

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 26

At #ESMO26: in the phase 2 MDT-BRIDGE trial, neoadjuvant durvalumab + chemotherapy in patients with resectable NSCLC, followed by multidisciplinary reassessment, enabled surgery in the majority of patients, leading to encouraging response rates dlvr.​it/TW3jXV

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 25

At #ESMO26: In an analysis of the phase 3 RELATIVITY-047 trial comparing relatlimab + nivolumab vs nivolumab alone in patients with melanoma, high baseline levels of LAG3hi CD8+ T cells were associated with improved response in the combination arm dlvr.​it/TW34gN

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 24

At #ESMO26: In a phase 2a trial, treatment of patients with immune checkpoint-inhibitor-naive bladder cancer with the GDF15-neutralizing antibody visugromab + nivolumab produced encouraging response with no new safety signals @AndreaNecchi dlvr.​it/TW32cC

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 23

CAR-T therapies are generating excitement beyond cancer, with trials in autoimmune disease. But recent results have complicated that picture. In our latest news story, Marianne Guenot asks what the latest developments mean for the field. Read more: dlvr.​it/TW2LG7

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 23

A high-profile chronotherapy trial was retracted. What does the fallout mean for a field built around the idea that when we treat disease can matter? Natalie Healey investigates what comes next for chronotherapy in NatureMedicine. Read more: dlvr.​it/TW2KzW

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 23

News & Views: New studies of trends in the global burden of #measles and #pertussis offer a reminder of how much vaccination has achieved, and a warning of the need for more resilient and sustainable vaccination programs. dlvr.​it/TW2FXZ

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 23

Now #ESMO26: In a phase 2 trial evaluating an off-the-shelf peptide vaccine in patients with mKRAS PDAC, the 1ry endpoint of DFS was not met but prespecified analyses showed that significant DFS was seen in the vaccine arm in patients with ctDNA- disease. dlvr.​it/TW27M9

Post attachment
Nature Medicine avatar
Nature Medicine@NatureMedicine·Oct 23

As presented at #ESMO26: In a phase 1/2 trial in patients with solid tumors, a first-in-class bispecific antibody targeting the Vβ6/Vβ10 T cell subsets was well tolerated and showed preliminary efficacy signals in immunologically hot and cold tumors dlvr.​it/TW276w

Post attachment